within Pharmacolibrary.Drugs.ATC.P;

model P01BC01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.76,
    Cl             = 1e-06,
    adminDuration  = 600,
    adminMass      = 600 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0022,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 600,            
    Vdp             = 0.0015,
    k12             = 0.08,
    k21             = 0.08
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>P01BC01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Quinine is an alkaloid derived from the bark of the cinchona tree. It is primarily used as an antimalarial agent and is effective against Plasmodium falciparum malaria. Quinine has also been used historically for treatment of muscle cramps, but its primary approved use today is for malaria treatment, especially for severe cases or in regions with chloroquine-resistant malaria.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics of quinine in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Newton, P, et al., &amp; White, NJ (2001). Oral quinine pharmacokinetics and dietary salt intake. <i>European journal of clinical pharmacology</i> 57(2) 111–113. DOI:<a href=\"https://doi.org/10.1007/s002280100283\">10.1007/s002280100283</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11417441/\">https://pubmed.ncbi.nlm.nih.gov/11417441</a></p></li><li><p>Viriyayudhakorn, S, et al., &amp; Wanwimolruk, S (2000). Pharmacokinetics of quinine in obesity. <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i> 94(4) 425–428. DOI:<a href=\"https://doi.org/10.1016/s0035-9203(00)90128-7\">10.1016/s0035-9203(00)90128-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11127249/\">https://pubmed.ncbi.nlm.nih.gov/11127249</a></p></li><li><p>Hasan, MM, et al., &amp; Rawashdeh, NM (1990). Effect of oral activated charcoal on the pharmacokinetics of quinidine and quinine administered intravenously to rabbits. <i>Pharmacology &amp; toxicology</i> 67(1) 73–76. DOI:<a href=\"https://doi.org/10.1111/j.1600-0773.1990.tb00785.x\">10.1111/j.1600-0773.1990.tb00785.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2395819/\">https://pubmed.ncbi.nlm.nih.gov/2395819</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end P01BC01;
